1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors
ePostersLive by SciGen Technologies S.A. All rights reserved.
SOHO 2026 Annual Meeting
September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas
AML - 1029
Transplant Outcomes and Rates of Graft-Versus-Host Disease for FLT3-ITD Acute Myeloid Leukemia by Graft Source in the Era of Posttransplant Gilteritinib Maintenance
Poster Presenter
Authors
Part of Topic
Acute Myeloid Leukemia (AML)
Transplant Outcomes and Rates of Graft-Versus-Host Disease for FLT3-ITD Acute Myeloid Leukemia by Graft Source in the Era of Post-Transplant Gilteritinib Maintenance
Joseph Mort, MD1, Mark Levis, MD, PhD1, Alex Ambinder, MD, MPH1
1Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA
KEYWORDS: acute myeloid leukemia, FLT3-ITD, allogeneic HCT, FLT3 inhibitor, graft source
Aim: To assess the impact of graft source on rates of acute and chronic GVHD and GVHD-free, relapse-free survival (GRFS) in patients with FLT3-ITD AML and the ability to deliver gilteritinib maintenance